BTC
UTHR icon

Bank & Trust Company’s United Therapeutics UTHR Stock Holding History

Bank & Trust Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Sell
1,215
-156
-11% -$87.9K 0.42% 62
2026
Q1 		$813K Hold
1,371
– – 0.55% 49
2025
Q4 		$668K Hold
1,371
– – 0.47% 55
2025
Q3 		$575K Hold
1,371
– – 0.42% 66
2025
Q2 		$394K Buy
1,371
+52
+4% +$15.5K 0.31% 69
2025
Q1 		$407K Hold
1,319
– – 0.33% 69
2024
Q4 		$465K Hold
1,319
– – 0.39% 66
2024
Q3 		$473K Hold
1,319
– – 0.38% 64
2024
Q2 		$420K Buy
+1,319
New +$349K 0.36% 66

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bank & Trust Company's UTHR Position: Q2 2026 in Review

Bank & Trust Company reduced its United Therapeutics (UTHR) stake by 11% in Q2 2026, selling an estimated $87.9K and leaving 1,215 shares worth $658K. The position accounts for 0.42% of the portfolio, ranked #62.

Bank & Trust Company first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $813K in Q1 2026. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Bank & Trust Company held 1,215 shares of United Therapeutics worth $658K as of Q2 2026.
  • Bank & Trust Company sold 156 United Therapeutics shares in Q2 2026, an estimated $87.9K.
  • United Therapeutics made up 0.42% of Bank & Trust Company's portfolio in Q2 2026, its #62 holding.
  • Bank & Trust Company first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Bank & Trust Company's United Therapeutics position peaked at $813K in Q1 2026.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.